-
1.
公开(公告)号:US20240033344A1
公开(公告)日:2024-02-01
申请号:US18036681
申请日:2021-11-15
Applicant: BioNTech SE
Inventor: Heinrich Haas , Kaushik Thanki , Isaac Hernan Esparza Borquez , Sebastian Hörner , Bulat Sydykov , Martin Kapp
IPC: A61K39/215 , A61K47/26 , A61K9/51 , A61K9/19
CPC classification number: A61K39/215 , A61K47/26 , A61K9/5123 , A61K9/5192 , A61K9/19 , A61K2039/55555
Abstract: The present disclosure relates generally to the field of pharmaceutical compositions comprising particles, in particular lipid nanoparticles (LNPs), and mRNA, methods for preparing and storing such pharmaceutical compositions, and the use of pharmaceutical compositions in therapy.
-
公开(公告)号:US20230414516A1
公开(公告)日:2023-12-28
申请号:US18036676
申请日:2021-11-15
Applicant: BioNTech SE
Inventor: Bakul Subodh Bhatnagar , Ramin Darvari , Sumit Luthra , Serguei A. Tchessalov , Steffen Panzner , Christian Reinsch , Kaushik Thanki , Sukrut Somani
IPC: A61K9/19 , A61K9/16 , A61K9/51 , A61K31/7105
CPC classification number: A61K9/19 , A61K9/1694 , A61K9/1623 , A61K9/5123 , A61K31/7105
Abstract: This invention relates to enhanced stabilization and improved lyophilization methods of pharmaceutical substances.
-
公开(公告)号:US20240041785A1
公开(公告)日:2024-02-08
申请号:US18036679
申请日:2021-11-14
Applicant: BioNTech SE
Inventor: Steffen Panzner , Christian Reinsch , Kaushik Thanki , Sukrut Somani , Serguei A. Tchessalov , Bakul Subodh Bhatnagar , Ramin Darvari , Sumit Luthra
CPC classification number: A61K9/5123 , A61K47/24 , A61K47/18 , A61K47/28 , A61K9/5146 , A61K47/26 , A61K9/5192 , A61K39/215 , A61K2039/6018
Abstract: The present disclosure provides technologies relating to stabilization of lipid nanoparticle mRNA compositions (e.g., vaccines).
-
公开(公告)号:US20230414747A1
公开(公告)日:2023-12-28
申请号:US18036677
申请日:2021-11-15
Applicant: BioNTech SE
Inventor: Steffen Panzner , Ugur Sahin , Jorrit-Jan Krijger , Kaushik Thanki , Bakul Subodh Bhatnagar , Ramin Darvari , Sumit Luthra , Serguei A. Tchessalov
IPC: A61K39/215 , A61K9/51 , A61P31/14
CPC classification number: A61K39/215 , A61K9/5123 , A61P31/14 , C12N2770/20034 , A61K2039/53
Abstract: The present disclosure relates generally to the field of lipid nanoparticle (LNP) compositions comprising RNA, methods for preparing and storing such compositions, and the use of such compositions in therapy.
-
-
-